Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-20

Clinical Trial Update: Allopurinol in Functional Impairment (ALFIE) Trial: 'Improving Muscle Strength' [Phase 4]

View source ↗

Summary

The University of Dundee completed the Phase 4 ALFIE trial evaluating allopurinol for improving muscle strength in sarcopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: University of Dundee | Conditions: Sarcopenia | Phase 4 | Status: COMPLETED